Where is the proof that polypharmacy is effective? [1]

Drug Benefit Trends

Volumn 17, Issue 12, 2005, Pages 554-557

  Ruthven, Les ^a  

^a Oklahoma State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PSYCHOTROPIC AGENT;

CLINICAL PRACTICE; COMORBIDITY; DEPRESSION; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MARKETING; DRUG USE; EVIDENCE BASED PRACTICE; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; LETTER; MANAGED CARE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MENTAL HEALTH CARE; POLYPHARMACY; PRESCRIPTION; PSYCHIATRY;

EID: 33750803690     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Ruthven L. Antidepressants: Science, Magic or Marketing? Wichita, Kan: Preferred Mental Health Management Publishing; 2005.
2. Khan A, Khan S, Brown WA. Are placebo controls necessary to test new antidepressants and anxiolytics? Int J Neuropsychopharmacol. 2002;5:193-197.